Implications of Pharma MNCs Exit – Asrar Qureshi’s Blog Post #824
Implications of Pharma MNCs Exit – Asrar Qureshi’s Blog Post #824 Dear Colleagues! This is Asrar Qureshi’s Blog Post #824 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Anna Tarazevich Photo Credit: cottonbro studio Photo Credit: Tima Miroshnichenko When I joined Pharma industry in 1975, there were around 50 multinational pharmaceutical companies in the market; the number of local companies would be around 100. The market was dominated by MNCs with over 80% market share. Presently, the number of MNCs has decreased to under 20. Some merged, while others rolled back operations. Most notable exits have been Roche, MSD, Merck Marker, Pfizer, Eli Lilly, Janssen, Fresenius Kabi, Sanofi, and Bayer. Pharma MNCs are not the ...